CLMT
Calumet, Inc. NASDAQ Listed Jan 26, 2006$34.59
After hrs
$32.09
+0.03%
Mkt Cap $3.0B
52w Low $11.38
90.8% of range
52w High $36.94
50d MA $31.39
200d MA $22.32
P/E (TTM)
-86.4x
EV/EBITDA
8.3x
P/B
—
Debt/Equity
-0.5x
ROE
4.6%
P/FCF
30.5x
RSI (14)
—
ATR (14)
—
Beta
0.85
50d MA
$31.39
200d MA
$22.32
Avg Volume
1.4M
Calumet, Inc. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
2780 Waterfront Parkway East Drive · Indianapolis, IN 46214 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | AMC | -0.67 | -0.43 | +35.8% | 26.96 | +2.0% | +1.7% | +3.4% | +8.8% | +12.4% | +12.8% | — |
| Nov 7, 2025 | AMC | -0.30 | -0.21 | +30.0% | 19.19 | +0.5% | -0.2% | +0.5% | -1.4% | -4.6% | -2.7% | — |
| Aug 8, 2025 | AMC | -0.44 | -1.70 | -286.4% | 14.37 | +0.2% | -7.7% | -1.6% | -0.6% | -4.3% | -5.4% | — |
| May 9, 2025 | AMC | -0.41 | -1.03 | -151.2% | 12.32 | +5.0% | +6.5% | +13.6% | +12.6% | +9.2% | +11.4% | — |
| Feb 28, 2025 | AMC | -1.06 | -0.47 | +55.7% | 14.33 | -0.2% | -6.1% | -9.0% | -9.4% | -13.1% | -16.5% | — |
| Nov 8, 2024 | AMC | -0.59 | -0.81 | -37.3% | 22.24 | -0.2% | +0.0% | -8.6% | -10.5% | -7.9% | -5.9% | — |
| Aug 9, 2024 | AMC | -0.70 | -0.48 | +31.4% | 13.64 | -0.7% | +4.0% | +17.2% | +16.9% | +26.8% | +24.3% | — |
| May 10, 2024 | AMC | -0.74 | -0.61 | +17.6% | 15.97 | -0.4% | -4.8% | -3.3% | -3.8% | -1.4% | -1.3% | — |
| Feb 23, 2024 | AMC | -0.44 | -0.79 | -79.5% | 16.60 | -1.4% | +0.8% | -5.1% | -7.3% | -6.4% | -5.4% | — |
| Nov 9, 2023 | AMC | -0.13 | 0.03 | +123.1% | 14.25 | +2.2% | +5.2% | +6.9% | +4.7% | +2.8% | +1.0% | — |
| Aug 4, 2023 | AMC | -0.07 | -0.19 | -171.4% | 15.56 | -0.3% | +0.9% | +0.6% | +1.5% | +1.6% | +3.7% | — |
| May 5, 2023 | AMC | 0.02 | 0.10 | +390.0% | 17.44 | +3.8% | -0.1% | -2.0% | -3.2% | -4.0% | -4.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Goldman Sachs | Downgrade | Buy → Neutral | $36 | $32.78 | $31.98 | -2.4% | -6.7% | -6.2% | -6.9% | -0.8% | -0.2% |
| Mar 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.06 | $33.83 | +5.5% | +9.3% | +12.0% | +7.9% | +9.4% | +11.4% |
| Mar 12 | Goldman Sachs | Maintains | Buy → Buy | — | $29.08 | $29.77 | +2.4% | -1.2% | -1.7% | -2.8% | -1.5% | +0.1% |
| Jan 30 | Goldman Sachs | Maintains | Buy → Buy | — | $22.39 | $22.27 | -0.5% | +0.1% | +1.5% | +7.1% | +9.5% | +9.6% |
| Nov 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.19 | $19.28 | +0.5% | -0.2% | +0.5% | -1.4% | -4.6% | -2.7% |
| Oct 22 | Goldman Sachs | Maintains | Buy → Buy | — | $18.67 | $19.14 | +2.5% | +5.2% | +7.1% | +7.7% | +7.7% | +6.6% |
| Aug 12 | UBS | Maintains | Neutral → Neutral | — | $13.27 | $13.27 | +0.0% | +6.6% | +7.7% | +3.6% | +2.5% | -0.3% |
| May 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.00 | $13.91 | -0.6% | -0.9% | -3.9% | -1.9% | -1.3% | -1.6% |
| Apr 30 | Goldman Sachs | Maintains | Buy → Buy | — | $10.86 | $10.57 | -2.7% | -2.4% | -1.6% | +3.6% | +2.2% | +2.9% |
| Apr 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $8.99 | $8.30 | -7.7% | +12.5% | +1.8% | +10.2% | +3.6% | +5.1% |
| Mar 17 | UBS | Upgrade | Sell → Neutral | — | $12.06 | $12.73 | +5.6% | +9.4% | +6.6% | +9.6% | +10.9% | +5.5% |
| Mar 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $13.04 | $12.77 | -2.1% | -0.5% | -4.5% | -8.2% | -16.0% | -17.3% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.33 | $14.30 | -0.2% | -6.1% | -9.0% | -9.4% | -13.1% | -16.5% |
| Feb 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.88 | $19.00 | +19.6% | +9.6% | +4.2% | +4.3% | +1.3% | -2.6% |
| Feb 4 | UBS | Downgrade | Neutral → Sell | — | $18.34 | $16.70 | -8.9% | -7.3% | -9.3% | -10.0% | -11.6% | -11.9% |
| Jan 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.75 | $22.65 | +4.1% | +1.1% | -12.8% | -13.0% | -16.5% | -15.4% |
| Nov 11 | TD Cowen | Maintains | Buy → Buy | — | $22.24 | $22.20 | -0.2% | +0.0% | -8.6% | -10.5% | -7.9% | -5.9% |
| Nov 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.24 | $22.20 | -0.2% | +0.0% | -8.6% | -10.5% | -7.9% | -5.9% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.64 | $13.54 | -0.7% | +4.0% | +17.2% | +16.9% | +26.8% | +24.3% |
| Aug 12 | TD Cowen | Maintains | Buy → Buy | — | $13.64 | $13.54 | -0.7% | +4.0% | +17.2% | +16.9% | +26.8% | +24.3% |
| Aug 5 | Goldman Sachs | Maintains | Buy → Buy | — | $11.84 | $11.00 | -7.1% | -3.1% | +0.0% | -4.9% | -0.4% | +15.2% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.97 | $15.90 | -0.4% | -4.8% | -3.3% | -3.8% | -1.4% | -1.3% |
| Apr 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.98 | $15.01 | +0.2% | +2.6% | +8.1% | +4.0% | +4.6% | +3.6% |
| Mar 21 | Goldman Sachs | Maintains | Buy → Buy | — | $14.41 | $14.31 | -0.7% | +0.5% | +0.3% | -1.3% | -4.2% | -0.2% |
| Dec 14 | Goldman Sachs | Maintains | Buy → Buy | — | $17.20 | $17.12 | -0.5% | +0.9% | -1.3% | -4.8% | -5.1% | -4.2% |
| Oct 31 | Goldman Sachs | Maintains | Buy → Buy | — | $13.37 | $13.23 | -1.0% | -2.5% | -3.4% | -1.4% | +4.2% | +1.5% |
| Aug 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.56 | $15.52 | -0.3% | +0.9% | +0.6% | +1.5% | +1.6% | +3.7% |
| Jun 13 | Goldman Sachs | Maintains | Buy → Buy | — | $15.57 | $15.79 | +1.4% | -1.1% | -1.7% | -0.1% | +0.1% | +2.9% |
| May 15 | UBS | Maintains | Neutral → Neutral | — | $16.62 | $16.62 | +0.0% | +0.4% | +1.7% | +2.2% | -0.2% | +0.2% |
| May 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $17.44 | $18.11 | +3.8% | -0.1% | -2.0% | -3.2% | -4.0% | -4.7% |
| May 8 | TD Cowen | Maintains | Outperform → Outperform | — | $17.44 | $18.11 | +3.8% | -0.1% | -2.0% | -3.2% | -4.0% | -4.7% |
| Jan 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.65 | $16.57 | -0.5% | +1.3% | +1.9% | -0.2% | -2.1% | -2.2% |
| Dec 14 | UBS | Maintains | Neutral → Neutral | — | $14.02 | $14.30 | +2.0% | -0.6% | +4.0% | +0.4% | -1.4% | -2.4% |
| Aug 18 | Goldman Sachs | Upgrade | Neutral → Buy | — | $16.68 | $17.05 | +2.2% | +4.7% | +0.4% | +2.3% | +5.8% | +7.1% |
| Jun 28 | Cowen & Co. | Maintains | Outperform → Outperform | — | $11.52 | $12.08 | +4.9% | -0.3% | -6.2% | -9.8% | -11.3% | -22.0% |
| May 9 | Cowen & Co. | Maintains | Outperform → Outperform | — | $14.32 | $14.74 | +2.9% | -12.7% | -13.0% | -8.2% | -8.7% | -5.7% |
| Apr 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.27 | $14.41 | +1.0% | -3.1% | -1.9% | +0.5% | +5.2% | +10.3% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.68 | $14.92 | +1.6% | +5.6% | +0.4% | +3.3% | +5.8% | +5.3% |
| Nov 23 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $15.20 | $16.16 | +6.3% | -0.1% | -1.2% | +5.9% | +9.0% | -2.8% |
| Nov 23 | Cowen & Co. | Upgrade | Market Perform → Outperform | — | $15.20 | $16.16 | +6.3% | -0.1% | -1.2% | +5.9% | +9.0% | -2.8% |
| Oct 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $10.63 | $10.58 | -0.5% | -1.1% | -0.9% | -3.1% | +0.1% | +5.0% |
| Oct 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.40 | $9.60 | +2.1% | +15.6% | +15.3% | +15.0% | +16.1% | +13.1% |
| Oct 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.03 | $8.19 | +2.0% | +9.5% | +19.7% | +19.1% | +17.1% | +35.4% |
| Mar 24 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $5.28 | $5.74 | +8.7% | +10.2% | +15.9% | +13.3% | +11.4% | +11.6% |
| Dec 15 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $3.83 | $3.72 | -2.9% | +0.3% | +0.0% | -0.8% | -1.0% | -9.1% |
| Mar 27 | Goldman Sachs | Maintains | Neutral → Neutral | — | $1.22 | $1.26 | +3.3% | -4.1% | -11.5% | -13.9% | -19.7% | -19.7% |
| Feb 11 | Raymond James | Upgrade | Underperform → Market Perform | — | $4.07 | $4.28 | +5.2% | +3.9% | +4.4% | +3.9% | +4.4% | +2.9% |
| Oct 2 | Wells Fargo | Maintains | Outperform → Outperform | — | $8.35 | $8.45 | +1.2% | +3.6% | +1.2% | +2.4% | +3.6% | +3.0% |
| Sep 5 | Janney Montgomery Scott | Downgrade | Buy → Neutral | — | $8.40 | $8.15 | -3.0% | -4.8% | -4.2% | -6.0% | -7.7% | -5.4% |
| Sep 5 | Janney Capital | Downgrade | Buy → Neutral | — | $8.40 | $8.15 | -3.0% | -4.8% | -4.2% | -6.0% | -7.7% | -5.4% |
No insider trades available.
8-K
Calumet, Inc. -- 8-K Filing
Calumet's Montana Renewables facility achieved operational startup in May 2024 following EPA's renewable fuel mandate announcement, positioning the company to capitalize on strengthened margins in both traditional and renewable energy markets.
May 8
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A board member's non-reelection at Calumet suggests potential leadership transitions or strategic shifts that could indicate internal disagreements or governance changes affecting management direction and investor confidence.
Mar 25
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Celmate signed a material agreement that could significantly impact operations or financial results, requiring investors to monitor the full filing details to assess whether this represents a strategic opportunity or potential risk to shareholder value.
Mar 17
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Bank of America secured a new financing or debt agreement through its securities subsidiary, which could indicate capital restructuring or new funding needs that may impact leverage ratios and investor returns.
Mar 13
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Bank of America announced a tack-on offering on March 12, 2026, likely involving additional security issuance that could dilute shareholder equity and potentially signal capital management adjustments affecting near-term stock performance.
Mar 12
8-K
Calumet, Inc. -- 8-K Filing
Calumet reported a net loss of $33.8 million in fiscal 2025 but achieved $293.3 million adjusted EBITDA, reduced debt by $222 million, and projects strong free cash flow from $100 million cost cuts.
Feb 27
Data updated apr 25, 2026 1:42am
· Source: massive.com